Cargando…
A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer
A phase I study was carried out to determine the optimal dose and administration schedule for combined UFT plus gemcitabine therapy in patients with non-small cell lung cancer. Twenty-four patients (including 11 patients previously treated with cisplatin as the key drug) received oral UFT 400 mg m(−...
Autores principales: | Seto, T, Yoh, K, Asoh, H, Yamamoto, H, Semba, H, Ichinose, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375416/ https://www.ncbi.nlm.nih.gov/pubmed/12087453 http://dx.doi.org/10.1038/sj.bjc.6600337 |
Ejemplares similares
-
UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial
por: Ichinose, Y, et al.
Publicado: (2005) -
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
por: Oh, S C, et al.
Publicado: (2005) -
Phase II trial of UFT in advanced colorectal and gastric cancer.
por: Malik, S. T., et al.
Publicado: (1990) -
A phase I study of oral UFT/leucovorin and irinotecan, plus radiation for locally recurrent rectal cancer
por: Ikeda, Masataka, et al.
Publicado: (2018) -
Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer
por: Kurata, T, et al.
Publicado: (2004)